| __timestamp | Regeneron Pharmaceuticals, Inc. | Vertex Pharmaceuticals Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 205018000 | 60987000 |
| Thursday, January 1, 2015 | 392709000 | 125542000 |
| Friday, January 1, 2016 | 299694000 | 210460000 |
| Sunday, January 1, 2017 | 397061000 | 275119000 |
| Monday, January 1, 2018 | 434100000 | 409539000 |
| Tuesday, January 1, 2019 | 782200000 | 547758000 |
| Wednesday, January 1, 2020 | 1119900000 | 736300000 |
| Friday, January 1, 2021 | 2437500000 | 904200000 |
| Saturday, January 1, 2022 | 1560400000 | 1080300000 |
| Sunday, January 1, 2023 | 1815800000 | 1262200000 |
| Monday, January 1, 2024 | 1970500000 | 1530500000 |
Unleashing insights
In the competitive landscape of pharmaceuticals, cost efficiency is a critical metric. Over the past decade, Regeneron Pharmaceuticals, Inc. and Vertex Pharmaceuticals Incorporated have demonstrated distinct trajectories in managing their cost of revenue. From 2014 to 2023, Regeneron consistently outpaced Vertex, with its cost of revenue peaking at approximately 2.4 billion in 2021, a staggering 300% increase from 2014. Meanwhile, Vertex showed a steady rise, reaching its highest in 2023 at around 1.3 billion, marking a 20-fold increase since 2014. This comparison highlights Regeneron's aggressive scaling and Vertex's steady growth. As the pharmaceutical industry continues to evolve, these trends offer valuable insights into each company's operational strategies and market positioning. Understanding these dynamics is crucial for investors and stakeholders aiming to navigate the complexities of the healthcare sector.
Eli Lilly and Company vs Regeneron Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Research and Development Investment: Vertex Pharmaceuticals Incorporated vs Regeneron Pharmaceuticals, Inc.
Cost of Revenue Comparison: Vertex Pharmaceuticals Incorporated vs Dr. Reddy's Laboratories Limited
Cost Insights: Breaking Down Vertex Pharmaceuticals Incorporated and Alkermes plc's Expenses
Cost of Revenue Comparison: Vertex Pharmaceuticals Incorporated vs Supernus Pharmaceuticals, Inc.
Vertex Pharmaceuticals Incorporated vs Wave Life Sciences Ltd.: Efficiency in Cost of Revenue Explored
Cost Insights: Breaking Down Regeneron Pharmaceuticals, Inc. and Halozyme Therapeutics, Inc.'s Expenses
Regeneron Pharmaceuticals, Inc. vs Grifols, S.A.: Efficiency in Cost of Revenue Explored
Cost of Revenue Trends: Regeneron Pharmaceuticals, Inc. vs Cytokinetics, Incorporated
Cost of Revenue Trends: Regeneron Pharmaceuticals, Inc. vs PTC Therapeutics, Inc.
Analyzing Cost of Revenue: Regeneron Pharmaceuticals, Inc. and MiMedx Group, Inc.